Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: HHS

Research Roundup: Study finds malaria drug helps improve COVID-19 patients, J&J and Moderna sign deals with US to produce coronavirus vaccines, and FDA authorizes 15-minute coronavirus test
PATH/Patrick McKern
April 6, 2020

Research Roundup: Study finds malaria drug helps improve COVID-19 patients, J&J and Moderna sign deals with US to produce coronavirus vaccines, and FDA authorizes 15-minute coronavirus test

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: Ebola vaccine licensed in five African countries, Sanofi & HHS to develop COVID-19 vaccine, and digital AMR platform in Zambia
PATH/Matthew Dakin
February 24, 2020

Research Roundup: Ebola vaccine licensed in five African countries, Sanofi & HHS to develop COVID-19 vaccine, and digital AMR platform in Zambia

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Trump signs spending bill boosting funding for health research
PATH/Patrick McKern
September 27, 2018

Trump signs spending bill boosting funding for health research

President Trump signed into law a spending bill that pairs full-year fiscal year (FY) 2019 funding for Labor, Health and Human Services (LHHS) and Defense with a stopgap measure to keep other agencies funded through December—staving off a partial government shutdown on the eve of the end of the fiscal year. Here’s a breakdown of how global health and medical research funding fared.

Emily Conron GHTC
Read More
Research Roundup: US launches biodefense strategy, TB remains world's top infectious killer, and human trials begin for antimalarial drug
PATH/Wendy Stone
September 23, 2018

Research Roundup: US launches biodefense strategy, TB remains world's top infectious killer, and human trials begin for antimalarial drug

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Global health and medical research saved from the chopping block in 2018 spending bill
Flickr/55thstreet
March 28, 2018

Global health and medical research saved from the chopping block in 2018 spending bill

What global health R&D advocates need to know about the 2018 omnibus spending bill.

Marissa Chmiola GHTC
Read More
Health R&D saves lives, spurs innovation, and solidifies success
PATH/Gabe Bienczycki
March 5, 2018

Health R&D saves lives, spurs innovation, and solidifies success

USAID’s latest report to Congress demonstrates how strategic R&D investments are driving positive global health outcomes and saving American taxpayers money

Matt Barnhart US Agency for International Development
Read More
Five issues to watch in US global health R&D policy in 2018
PATH/Aaron Joel Santos
January 8, 2018

Five issues to watch in US global health R&D policy in 2018

2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.

Courtney Carson
GHTC
Read More
Global health and medical research saved from spending cuts in FY17 budget agreement
Architect of the Capitol
May 2, 2017

Global health and medical research saved from spending cuts in FY17 budget agreement

What global health R&D advocates need to know about the FY2017 budget agreement.

Courtney Carson
GHTC
Read More
Trump budget proposes steep cuts to research and foreign assistance that will threaten global health research
Office of Management and Budget
March 21, 2017

Trump budget proposes steep cuts to research and foreign assistance that will threaten global health research

What global health advocates need to know about the President's "skinny" budget.

Courtney Carson
GHTC
Read More
Price addresses innovation, infectious diseases, NIH support at nomination hearings
Flickr/Mark Taylor
January 26, 2017

Price addresses innovation, infectious diseases, NIH support at nomination hearings

At his nomination hearings, Secretary of Health and Human Services-designee Tom Price addressed global health and infectious diseases; innovation for rare diseases; support for health innovation, NIH, and priority setting for NIH-funded research. GHTC covers what he had to say.

Courtney Carson
GHTC
Read More
Research Roundup: Clinical trial data, Mayaro virus, antimicrobial resistance, and more
CDC/James Gathany
September 25, 2016

Research Roundup: Clinical trial data, Mayaro virus, antimicrobial resistance, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Kat Kelly
GHTC
Read More
Research Roundup: Antibiotics, Zika vaccine R&D, and Ebola and malaria co-infection
David Jacobs
August 21, 2016

Research Roundup: Antibiotics, Zika vaccine R&D, and Ebola and malaria co-infection

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Kat Kelly
GHTC
Read More
GHTC briefing highlights critical role of US government in advancing global health innovation in an increasingly globalized world
GHTC/Marissa Chmiola
April 24, 2016

GHTC briefing highlights critical role of US government in advancing global health innovation in an increasingly globalized world

On Tuesday, GHTC launched our seventh annual policy report through a congressional briefing and panel discussion. The critical role played by the US government in catalyzing global health research and development was a recurring theme, as panelists discussed the interconnectedness of global and American health and emphasized the need for new health tools to protect against outbreaks and continue progress.

Kat Kelly
GHTC
Read More
President will redirect Ebola funds for Zika, but where is the money from and where will it go?
April 7, 2016

President will redirect Ebola funds for Zika, but where is the money from and where will it go?

The Administration announced that it will transfer nearly $600 million in remaining Ebola funds to fight the growing threat of Zika virus. But many questions remain. Where is the money going? What accounts is it coming from? And what does this mean for the Global Health Security Agenda?

Courtney Carson
GHTC
Read More
Research Roundup: a promising Ebola treatment, access to drugs for NCDs, a new approach to treating a deadly bacterium, and the perception of breakthrough drugs
PATH/Evelyn Hockstin
September 27, 2015

Research Roundup: a promising Ebola treatment, access to drugs for NCDs, a new approach to treating a deadly bacterium, and the perception of breakthrough drugs

The US Department of Health and Human Services (HHS) is partnering with New York–based Regeneron Pharmaceuticals, Inc. for the development of an Ebola treatment.

Kat Kelly
GHTC
Read More
Research Roundup: 3D-printed drugs, R&D in emergency settings, a universal flu vaccine, and more
August 9, 2015

Research Roundup: 3D-printed drugs, R&D in emergency settings, a universal flu vaccine, and more

The US Food and Drug Administration (FDA) approved the first 3D-printed drug last week, paving the way for the technology to be used to customize medical care to individual patients.

Kat Kelly
GHTC
Read More
GHTC briefing highlights importance of global health innovation in protecting US and world from threats like Ebola
PATH/Evelyn Hockstein
April 1, 2015

GHTC briefing highlights importance of global health innovation in protecting US and world from threats like Ebola

On Thursday, March 26, 2015, the Global Health Technologies Coalition (GHTC) launched its sixth annual policy report titled Meeting the challenge, seizing the opportunity: US leadership can advance global health R&D with a luncheon and panel discussion on Capitol Hill.

Kat Kelly
GHTC
Read More
Research Roundup: Drug-resistant malaria, MDGs, World Breastfeeding Week, LHHS appropriations, and more
PATH/Amy MacIver
August 3, 2014

Research Roundup: Drug-resistant malaria, MDGs, World Breastfeeding Week, LHHS appropriations, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Nick Taylor
GHTC
Read More
Senate supports global health R&D in LHHS appropriations bill
July 28, 2014

Senate supports global health R&D in LHHS appropriations bill

Last week, we reported on exciting policy language included in the Senate Department of Defense appropriations legislation, and earlier this summer, the House and Senate State and Foreign Operations bills also included recognition of the role that new technologies could play in advancing global health.

Ashley Bennett
GHTC
Read More
Congress acts on FY 2015 funding; shows lukewarm support for global health R&D
PATH/Will Boase
June 17, 2014

Congress acts on FY 2015 funding; shows lukewarm support for global health R&D

As the DC summer kicks into full swing, Congress has had a busy month moving forward fiscal year (FY) 2015 funding legislation for a variety of government programs including global health research and development (R&D).

Ashley Bennett
GHTC
Read More
  • 1
  • 2
  • Next
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.
Header Photo: PATH/Evelyn Hockstein

Site managed by A3CS

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In